Annual Current Assets
$554.69 M
-$96.61 M-14.83%
31 December 2023
Summary:
Lyell Immunopharma annual total current assets is currently $554.69 million, with the most recent change of -$96.61 million (-14.83%) on 31 December 2023. During the last 3 years, it has fallen by -$71.60 million (-11.43%). LYEL annual current assets is now -14.83% below its all-time high of $651.29 million, reached on 31 December 2022.LYEL Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Assets
$450.05 M
-$49.78 M-9.96%
30 September 2024
Summary:
Lyell Immunopharma quarterly total current assets is currently $450.05 million, with the most recent change of -$49.78 million (-9.96%) on 30 September 2024. Over the past year, it has dropped by -$104.64 million (-18.86%). LYEL quarterly current assets is now -46.09% below its all-time high of $834.84 million, reached on 30 June 2021.LYEL Quarterly Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
LYEL Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -18.9% |
| 3 y3 years | -11.4% | -28.1% |
| 5 y5 years | +26.0% | - |
LYEL Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -14.8% | at low | -32.5% | at low |
| 5 y | 5 years | -14.8% | +26.0% | -46.1% | at low |
| alltime | all time | -14.8% | +26.0% | -46.1% | at low |
Lyell Immunopharma Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $450.05 M(-10.0%) |
| June 2024 | - | $499.82 M(-6.4%) |
| Mar 2024 | - | $534.16 M(-3.7%) |
| Dec 2023 | $195.34 M(-31.8%) | $554.69 M(-5.5%) |
| Sept 2023 | - | $586.85 M(-3.2%) |
| June 2023 | - | $606.41 M(-2.9%) |
| Mar 2023 | - | $624.40 M(-4.1%) |
| Dec 2022 | $286.27 M | $651.29 M(-1.3%) |
| Sept 2022 | - | $659.75 M(-1.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $666.78 M(+6.6%) |
| Mar 2022 | - | $625.71 M(-0.1%) |
| Dec 2021 | $501.12 M(+72.4%) | $626.29 M(-0.8%) |
| Sept 2021 | - | $631.15 M(-24.4%) |
| June 2021 | - | $834.84 M(+36.9%) |
| Mar 2021 | - | $609.74 M(-1.3%) |
| Dec 2020 | $290.73 M(+152.0%) | - |
| Dec 2020 | - | $617.55 M |
| Dec 2019 | $115.37 M | - |
FAQ
- What is Lyell Immunopharma annual total current assets?
- What is the all time high annual current assets for Lyell Immunopharma?
- What is Lyell Immunopharma quarterly total current assets?
- What is the all time high quarterly current assets for Lyell Immunopharma?
- What is Lyell Immunopharma quarterly current assets year-on-year change?
What is Lyell Immunopharma annual total current assets?
The current annual current assets of LYEL is $554.69 M
What is the all time high annual current assets for Lyell Immunopharma?
Lyell Immunopharma all-time high annual total current assets is $651.29 M
What is Lyell Immunopharma quarterly total current assets?
The current quarterly current assets of LYEL is $450.05 M
What is the all time high quarterly current assets for Lyell Immunopharma?
Lyell Immunopharma all-time high quarterly total current assets is $834.84 M
What is Lyell Immunopharma quarterly current assets year-on-year change?
Over the past year, LYEL quarterly total current assets has changed by -$104.64 M (-18.86%)